IL123095A0 - Pharmaceutical compositions containing fluconazole for inhibiting the growth of cancers - Google Patents

Pharmaceutical compositions containing fluconazole for inhibiting the growth of cancers

Info

Publication number
IL123095A0
IL123095A0 IL12309596A IL12309596A IL123095A0 IL 123095 A0 IL123095 A0 IL 123095A0 IL 12309596 A IL12309596 A IL 12309596A IL 12309596 A IL12309596 A IL 12309596A IL 123095 A0 IL123095 A0 IL 123095A0
Authority
IL
Israel
Prior art keywords
cancers
inhibiting
growth
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL12309596A
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/674,180 external-priority patent/US5908855A/en
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL123095A0 publication Critical patent/IL123095A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL12309596A 1995-08-04 1996-07-30 Pharmaceutical compositions containing fluconazole for inhibiting the growth of cancers IL123095A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US188995P 1995-08-04 1995-08-04
US08/674,180 US5908855A (en) 1996-07-16 1996-07-16 Compositions for treating viral infections
PCT/US1996/012474 WO1997005873A2 (en) 1995-08-04 1996-07-30 Use of fluconazole for inhibiting the growth of cancers

Publications (1)

Publication Number Publication Date
IL123095A0 true IL123095A0 (en) 1998-09-24

Family

ID=26669622

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12309596A IL123095A0 (en) 1995-08-04 1996-07-30 Pharmaceutical compositions containing fluconazole for inhibiting the growth of cancers

Country Status (18)

Country Link
EP (1) EP0841921A2 (en)
JP (1) JPH11510187A (en)
KR (1) KR19990036138A (en)
CN (1) CN1195288A (en)
AR (1) AR003175A1 (en)
AU (1) AU711966B2 (en)
BR (1) BR9609966A (en)
CA (1) CA2229024A1 (en)
CZ (1) CZ33798A3 (en)
HU (1) HUP9903420A3 (en)
IL (1) IL123095A0 (en)
MX (1) MX9800998A (en)
NO (1) NO980473L (en)
NZ (2) NZ315184A (en)
PL (1) PL324904A1 (en)
SK (1) SK14198A3 (en)
TR (2) TR199801739T2 (en)
WO (1) WO1997005873A2 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6177460B1 (en) 1995-04-12 2001-01-23 The Procter & Gamble Company Method of treatment for cancer or viral infections
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
US5770616A (en) 1995-06-07 1998-06-23 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers
US6686391B2 (en) 1995-08-04 2004-02-03 University Of Arizona Foundation N-chlorophenylcarbamate and N-chlorophenylthiocarbamate compositions
FR2742405B1 (en) * 1995-12-13 1998-02-27 Cgea Comp Gen Entre Auto DRIVE UNIT COULD BE COUPLED TO A ROLLING SPEAKER AND RESULTING VEHICLE
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
PE11499A1 (en) * 1997-05-16 1999-03-01 Procter & Gamble TREATMENT OF HIV AND CANCER
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
EP1949911A3 (en) 1998-11-09 2008-08-06 Biogen Idec, Inc. Treatment of chronique lymphocytic leukemia using chimeric anti-CD20 antibody.
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US7004915B2 (en) * 2001-08-24 2006-02-28 Kci Licensing, Inc. Negative pressure assisted tissue treatment system
EP1895012A1 (en) 2006-08-30 2008-03-05 Universitätsklinikum Freiburg Method for inducing tumor apoptosis by increasing nitric oxide levels
WO2008073961A2 (en) * 2006-12-12 2008-06-19 Emory University Compounds and methods for modulating the silencing of a polynucleotide of interest
WO2019185521A1 (en) * 2018-03-26 2019-10-03 Westfälische Wilhelms-Universität Münster Ergosterol-biosynthesis inhibitor and influenza virus infection

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196855A3 (en) * 1985-03-29 1989-04-12 Pfizer Inc. Tioconazole and related compounds for prevention of sexually transmitted diseases and control of herpetic infections
BE1004029A6 (en) * 1990-11-22 1992-09-08 Mol Omer De Pharmaceutical compound and pharmaceutical set for the treatment of cancer
US5565478A (en) * 1994-03-14 1996-10-15 The United States Of America As Represented By The Department Of Health & Human Services Combination therapy using signal transduction inhibitors with paclitaxel and other taxane analogs
US5665751A (en) * 1995-06-07 1997-09-09 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers

Also Published As

Publication number Publication date
NO980473L (en) 1998-04-03
NO980473D0 (en) 1998-02-03
AR003175A1 (en) 1998-07-08
MX9800998A (en) 1998-04-30
EP0841921A2 (en) 1998-05-20
HUP9903420A3 (en) 2001-12-28
TR199801739T2 (en) 1998-12-21
HUP9903420A2 (en) 2000-03-28
CZ33798A3 (en) 1998-06-17
AU6683396A (en) 1997-03-05
WO1997005873A2 (en) 1997-02-20
JPH11510187A (en) 1999-09-07
PL324904A1 (en) 1998-06-22
WO1997005873A3 (en) 1997-03-27
TR199800270T1 (en) 1998-05-21
KR19990036138A (en) 1999-05-25
NZ315184A (en) 2000-05-26
CN1195288A (en) 1998-10-07
SK14198A3 (en) 1999-03-12
AU711966B2 (en) 1999-10-28
CA2229024A1 (en) 1997-02-20
NZ503921A (en) 2002-03-01
BR9609966A (en) 1999-02-02

Similar Documents

Publication Publication Date Title
IL123095A0 (en) Pharmaceutical compositions containing fluconazole for inhibiting the growth of cancers
HK1002384A1 (en) Pharmaceutical compositions containing irbesartan
IL117873A0 (en) Pharmaceutical compositions for inhibiting the growth of viruses and cancers
HUP9802086A3 (en) Pharmaceutical composition for piperidinoalkanol compounds
HUP9802999A3 (en) Pharmaceutical composition containing n-propargyl-1-aminoindan
IL116455A0 (en) Imidazole compounds and pharmaceutical compositions containing them
HUP9602056A3 (en) Novel pharmaceutical composition containing phenofibrate
HUP9801532A3 (en) Use of benzimidazole derivatives for producing pharmaceutical compositions for inhibiting the growth of cancers
IL117957A0 (en) Pharmaceutical compositions for the treatment of impotence
NZ304982A (en) Pyridinyloxy- or pyridinylamino-acetamide derivatives; pharmaceutical compositions
ZA964377B (en) A pharmaceutical compositions for inhibiting the growth of cancers.
HU9800291D0 (en) Use of amido-pirimidine derivatives for producing pharmaceutical compositions for inhibiting decrease of glucose-metabolismus
ZA969248B (en) New aminoacid derivatives process for the manufacture thereof and pharmaceutical compositions containing thesse compounds
IL123094A0 (en) Pharmaceutical compositions containing griseofulvin for inhibiting the growth of cancers
IL117079A (en) Pharmaceutical compositions containing 2-phenyl-2-aroyl-benzothiophenes for inhibiting cell-cell adhesion
ZA962916B (en) New arylglycineamide derivatives processes for the manufacture thereof and pharmaceutical compositions containing these compounds
ZA962879B (en) A pharmaceutical composition for inhibiting the growth of viruses and cancers
IL117876A0 (en) Pharmaceutical compositions for inhibiting the growth of viruses and cancers
IL122717A0 (en) Compounds and pharmaceutical compositions containing them
ZA964374B (en) A pharmaceutical compositions for inhibiting the growth of cancers.
IL123093A0 (en) Pharmaceutical compositions containing 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers
HUP9900901A3 (en) A pharmaceutical composition containing n-chlorophenylcarbamates and n-chlorophenylthiocarbamates for inhibiting the growth of viruses and cancers
ZA962878B (en) A pharmaceutical composition for inhibiting the growth of viruses and cancers
IL117620A0 (en) Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same
ZA962880B (en) A pharmaceutical composition for inhibiting the growth of viruses and cancers